Shares of Globe Life Inc. (NYSE:GL – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the ten brokerages that are currently covering the stock, MarketBeat reports. Four research analysts have rated the stock with a hold recommendation, five have given a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year price target among brokerages that have issued ratings on the stock in the last year is $133.10.
A number of research analysts have recently weighed in on the company. Keefe, Bruyette & Woods lifted their price objective on Globe Life from $137.00 to $145.00 and gave the company an “outperform” rating in a research report on Wednesday, February 12th. Evercore ISI raised Globe Life from an “in-line” rating to an “outperform” rating and lifted their price objective for the company from $132.00 to $143.00 in a research report on Wednesday, January 8th. Piper Sandler lifted their price objective on Globe Life from $118.00 to $130.00 and gave the company an “overweight” rating in a research report on Friday, October 25th. BMO Capital Markets began coverage on Globe Life in a research report on Thursday, January 23rd. They set a “market perform” rating and a $114.00 price objective on the stock. Finally, Morgan Stanley boosted their price target on Globe Life from $123.00 to $125.00 and gave the stock an “equal weight” rating in a report on Tuesday, February 11th.
Read Our Latest Stock Analysis on GL
Globe Life Trading Up 1.7 %
Globe Life (NYSE:GL – Get Free Report) last posted its quarterly earnings data on Wednesday, February 5th. The company reported $3.14 earnings per share for the quarter, beating analysts’ consensus estimates of $3.12 by $0.02. Globe Life had a return on equity of 22.32% and a net margin of 18.53%. Analysts predict that Globe Life will post 13.57 EPS for the current year.
Insider Transactions at Globe Life
In other news, CEO Frank M. Svoboda sold 13,448 shares of the business’s stock in a transaction that occurred on Monday, January 6th. The stock was sold at an average price of $112.56, for a total transaction of $1,513,706.88. Following the transaction, the chief executive officer now owns 18,948 shares of the company’s stock, valued at approximately $2,132,786.88. The trade was a 41.51 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Mark A. Blinn sold 3,000 shares of the business’s stock in a transaction that occurred on Monday, January 6th. The shares were sold at an average price of $113.23, for a total value of $339,690.00. Following the transaction, the director now directly owns 5,122 shares in the company, valued at approximately $579,964.06. This represents a 36.94 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 75,678 shares of company stock valued at $8,799,822 in the last ninety days. Corporate insiders own 1.51% of the company’s stock.
Hedge Funds Weigh In On Globe Life
Large investors have recently modified their holdings of the stock. Versant Capital Management Inc grew its position in Globe Life by 388.0% in the 4th quarter. Versant Capital Management Inc now owns 244 shares of the company’s stock valued at $27,000 after acquiring an additional 194 shares during the last quarter. Albion Financial Group UT bought a new position in Globe Life in the 4th quarter valued at $28,000. Rakuten Securities Inc. bought a new position in Globe Life in the 4th quarter valued at $28,000. Avalon Trust Co bought a new position in Globe Life in the 4th quarter valued at $41,000. Finally, EverSource Wealth Advisors LLC grew its position in Globe Life by 32.7% in the 4th quarter. EverSource Wealth Advisors LLC now owns 365 shares of the company’s stock valued at $41,000 after acquiring an additional 90 shares during the last quarter. Institutional investors own 81.61% of the company’s stock.
About Globe Life
Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.
See Also
- Five stocks we like better than Globe Life
- What Are Growth Stocks and Investing in Them
- Hims & Hers Earnings Could Be a Game Changer—What to Do Now
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- DeepSeek IPO Remains Far Off—Investors Eye 4 Chinese AI Stocks
- ESG Stocks, What Investors Should Know
- Mortgage Market Bottom? Why Rocket Companies Could Be a Buy
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.